- Home
- ATAI vs ZIMV Comparison
ATAI vs ZIMV Comparison
Compare ATAI & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- ZIMV
- Stock Information
- Founded
- ATAI 2018
- ZIMV 2021
- Country
- ATAI Germany
- ZIMV United States
- Employees
- ATAI N/A
- ZIMV N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ATAI Health Care
- ZIMV Health Care
- Exchange
- ATAI Nasdaq
- ZIMV Nasdaq
- Market Cap
- ATAI 444.7M
- ZIMV 532.3M
- IPO Year
- ATAI 2021
- ZIMV N/A
- Fundamental
- Price
- ATAI $4.72
- ZIMV $18.90
- Analyst Decision
- ATAI Strong Buy
- ZIMV Hold
- Analyst Count
- ATAI 3
- ZIMV 3
- Target Price
- ATAI $13.33
- ZIMV $14.50
- AVG Volume (30 Days)
- ATAI 4.8M
- ZIMV 653.7K
- Earning Date
- ATAI 11-12-2025
- ZIMV 10-29-2025
- Dividend Yield
- ATAI N/A
- ZIMV N/A
- EPS Growth
- ATAI N/A
- ZIMV N/A
- EPS
- ATAI N/A
- ZIMV N/A
- Revenue
- ATAI $2,309,000.00
- ZIMV $443,402,000.00
- Revenue This Year
- ATAI $712.99
- ZIMV $2.49
- Revenue Next Year
- ATAI N/A
- ZIMV $1.26
- P/E Ratio
- ATAI N/A
- ZIMV N/A
- Revenue Growth
- ATAI 510.85
- ZIMV N/A
- 52 Week Low
- ATAI $1.03
- ZIMV $8.15
- 52 Week High
- ATAI $5.34
- ZIMV $19.01
- Technical
- Relative Strength Index (RSI)
- ATAI 61.12
- ZIMV 75.07
- Support Level
- ATAI $4.50
- ZIMV $18.85
- Resistance Level
- ATAI $4.75
- ZIMV $18.93
- Average True Range (ATR)
- ATAI 0.28
- ZIMV 0.05
- MACD
- ATAI -0.04
- ZIMV -0.15
- Stochastic Oscillator
- ATAI 59.28
- ZIMV 35.29
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.